Showing results (331-340 of 630) with videos related to
Sort By:
Pageof 63
The British Journal of Dermatology|February 10, 2023
Efficacy of downtitration or treatment withdrawal compared with continuous dosing after successful treatment with baricitinib in patients with moderate-to-severe atopic dermatitis in a randomized substudy from the long-term extension study BREEZE-AD3Kristian Reich, Eric Simpson, Andreas Wollenberg, et al.Dermatology and Therapy|June 19, 2024
Predicting Abrocitinib Efficacy at Week 12 Based on Clinical Response at Week 4: A Post Hoc Analysis of Four Randomized Studies in Moderate-to-Severe Atopic DermatitisApril W Armstrong, Andrew F Alexis, Andrew Blauvelt, et al.The Journal of Dermatological Treatment|September 11, 2023
Disease burden among patients with atopic dermatitis treated with systemic therapy for 4-12 months: results from the CorEvitas Atopic Dermatitis RegistryJonathan I Silverberg, Evangeline Pierce, Meghan Feely, et al.International Journal of Medical Sciences|July 9, 2009
Immune responses in autoimmune hepatitis: effect of prednisone and azathioprine treatment: case reportMartin H Bluth, Stephan Kohlhoff, Kevin B Norowitz, et al.Journal of the American Academy of Dermatology|October 16, 2016
Ten-year mortality is increased after hospitalization for atopic dermatitis compared with the general population, but reduced compared with psoriasisAlexander Egeberg, Lone Skov, Yuki M F Andersen, et al.Journal of the American Academy of Dermatology|August 16, 2019
Psoriasis and mortality in the United States: Data from the National Health and Nutrition Examination SurveyYevgeniy R Semenov, Christina M Herbosa, Andrew T Rogers, et al.Frontiers in Pediatrics|September 25, 2024
Dupilumab treatment reduces caregiver-reported skin pain in patients with moderate-to-severe atopic dermatitis aged 6 months to 5 yearsAmy S Paller, Jonathan I Silverberg, Mercedes E Gonzalez, et al.JAMA Dermatology|May 26, 2021
Incidence of Venous Thromboembolism in Patients With Dermatologist-Diagnosed Chronic Inflammatory Skin DiseasesMaria C Schneeweiss, Seoyoung C Kim, Richard Wyss, et al.Dermatology and Therapy|November 4, 2023
Next Generation PDE4 Inhibitors that Selectively Target PDE4B/D Subtypes: A Narrative ReviewAndrew Blauvelt, Richard G Langley, Kenneth B Gordon, et al.Journal of the European Academy of Dermatology and Venereology : JEADV|February 25, 2023
Higher levels of response on clinical atopic dermatitis severity measures are associated with meaningful improvements in patient-reported symptom and quality of life measures: Integrated analysis of three Upadacitinib phase 3 trialsK Reich, M S de Bruin-Weller, M Deleuran, et al.Pageof 63